Neurologic Improvement in Acute Cerebral Ischemia: Frequency, Magnitude, Predictors, and Clinical Outcomes.
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
07 03 2023
07 03 2023
Historique:
received:
27
01
2022
accepted:
20
10
2022
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
9
3
2023
Statut:
ppublish
Résumé
Investigations of rapid neurologic improvement (RNI) in patients with acute cerebral ischemia (ACI) have focused on RNI occurring after hospital arrival. However, with stroke routing decisions and interventions increasingly migrating to the prehospital setting, there is a need to delineate the frequency, magnitude, predictors, and clinical outcomes of patients with ACI with ultra-early RNI (U-RNI) in the prehospital and early postarrival period. We analyzed prospectively collected data of the prehospital Field Administration of Stroke Therapy-Magnesium (FAST-MAG) randomized clinical trial. Any U-RNI was defined as improvement by 2 or more points on the Los Angeles Motor Scale (LAMS) score between the prehospital and early post-emergency department (ED) arrival examinations and classified as moderate (2-3 point) or dramatic (4-5 point) improvement. Outcome measures included excellent recovery (modified Rankin Scale [mRS] score 0-1) and death by 90 days. Among the 1,245 patients with ACI, the mean age was 70.9 years (SD 13.2); 45% were women; the median prehospital LAMS was 4 (interquartile range [IQR] 3-5); the median last known well to ED-LAMS time was 59 minutes (IQR 46-80 minutes), and the median prehospital LAMS to ED-LAMS time was 33 minutes (IQR 28-39 minutes). Overall, any U-RNI occurred in 31%, moderate U-RNI in 23%, and dramatic U-RNI in 8%. Any U-RNI was associated with improved outcomes, including excellent recovery (mRS score 0-1) at 90 days 65.1% (246/378) vs 35.4% (302/852), U-RNI occurs in nearly 1 in 3 ambulance-transported patients with ACI and is associated with excellent recovery and decreased mortality at 90 days. Accounting for U-RNI may be useful for routing decisions and future prehospital interventions. TRIAL REGISTRATION INFORMATION: clinicaltrials.gov. Unique identifier: NCT00059332.
Sections du résumé
BACKGROUND AND OBJECTIVES
Investigations of rapid neurologic improvement (RNI) in patients with acute cerebral ischemia (ACI) have focused on RNI occurring after hospital arrival. However, with stroke routing decisions and interventions increasingly migrating to the prehospital setting, there is a need to delineate the frequency, magnitude, predictors, and clinical outcomes of patients with ACI with ultra-early RNI (U-RNI) in the prehospital and early postarrival period.
METHODS
We analyzed prospectively collected data of the prehospital Field Administration of Stroke Therapy-Magnesium (FAST-MAG) randomized clinical trial. Any U-RNI was defined as improvement by 2 or more points on the Los Angeles Motor Scale (LAMS) score between the prehospital and early post-emergency department (ED) arrival examinations and classified as moderate (2-3 point) or dramatic (4-5 point) improvement. Outcome measures included excellent recovery (modified Rankin Scale [mRS] score 0-1) and death by 90 days.
RESULTS
Among the 1,245 patients with ACI, the mean age was 70.9 years (SD 13.2); 45% were women; the median prehospital LAMS was 4 (interquartile range [IQR] 3-5); the median last known well to ED-LAMS time was 59 minutes (IQR 46-80 minutes), and the median prehospital LAMS to ED-LAMS time was 33 minutes (IQR 28-39 minutes). Overall, any U-RNI occurred in 31%, moderate U-RNI in 23%, and dramatic U-RNI in 8%. Any U-RNI was associated with improved outcomes, including excellent recovery (mRS score 0-1) at 90 days 65.1% (246/378) vs 35.4% (302/852),
DISCUSSION
U-RNI occurs in nearly 1 in 3 ambulance-transported patients with ACI and is associated with excellent recovery and decreased mortality at 90 days. Accounting for U-RNI may be useful for routing decisions and future prehospital interventions. TRIAL REGISTRATION INFORMATION: clinicaltrials.gov. Unique identifier: NCT00059332.
Identifiants
pubmed: 36878722
pii: WNL.0000000000201656
doi: 10.1212/WNL.0000000000201656
pmc: PMC9990857
doi:
Banques de données
ClinicalTrials.gov
['NCT00059332']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1038-e1047Informations de copyright
© 2022 American Academy of Neurology.
Références
Stroke. 1984 Nov-Dec;15(6):1039-44
pubmed: 6506115
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
Neurol Res Pract. 2021 Jun 1;3(1):31
pubmed: 34059132
Int J Stroke. 2014 Feb;9(2):220-5
pubmed: 24444117
Stroke. 2014 Jan;45(1):87-91
pubmed: 24281224
Stroke. 2017 Feb;48(2):298-306
pubmed: 28087807
JAMA Neurol. 2018 Nov 1;75(11):1364-1374
pubmed: 30039165
Stroke. 2012 Jun;43(6):1537-41
pubmed: 22492517
N Engl J Med. 2015 Feb 5;372(6):528-36
pubmed: 25651247
Stroke. 2008 Aug;39(8):2264-7
pubmed: 18556587
JAMA Neurol. 2021 Feb 1;78(2):157-164
pubmed: 33252631
Eur J Trauma Emerg Surg. 2021 Dec;47(6):1827-1835
pubmed: 32157340
Stroke. 2018 Mar;49(3):565-572
pubmed: 29459391
Neurology. 2014 Jun 17;82(24):2241-9
pubmed: 24850487
Prehosp Emerg Care. 2004 Jan-Mar;8(1):46-50
pubmed: 14691787
Alcohol Health Res World. 1997;21(1):21-9
pubmed: 15706760
J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1211-6
pubmed: 25869774
Lancet. 2019 Mar 9;393(10175):1009-1020
pubmed: 30738649
Int J Stroke. 2014 Feb;9(2):215-9
pubmed: 24444116
Stroke. 2022 Feb;53(2):482-487
pubmed: 34645285
Stroke. 2007 Sep;38(9):2531-5
pubmed: 17673713
J Stroke Cerebrovasc Dis. 2016 Apr;25(4):894-901
pubmed: 26825352
Stroke. 2000 Jan;31(1):71-6
pubmed: 10625718
Stroke. 2014 Jan;45(1):159-67
pubmed: 24203849